Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Denis Smith

Showing results (11-20 of 96) with videos related to

Pageof 10
Sort By:
Pharmacogenomics|December 19, 2007
Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcomeValérie Le Morvan, Denis Smith, Armelle Laurand, et al.
Pharmacogenomics|February 15, 2012
Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patientsAudrey Laroche-Clary, Audrey Kauffmann, Denis Smith, et al.
Fundamental & Clinical Pharmacology|September 8, 2016
How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospitalAmandine Gouverneur, Magali Rouyer, Angela Grelaud, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II studyEric Francois, Denis Smith, Laetitia Dahan, et al.
Targeted Oncology|December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohortAnnie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 12, 2021
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocolQuentin Denost, Eric Frison, Cécile Salut, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 18, 2021
Efficacy of treatments for VIPoma: A GTE multicentric seriesMathias Brugel, Thomas Walter, Bernard Goichot, et al.
Clinics and Research in Hepatology and Gastroenterology|November 22, 2017
Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine TumorsArnaud Plante, Eric Baudin, Christine Do Cao, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2007
Functional study of the 830C>G polymorphism of the human carboxylesterase 2 geneRicardo Bellott, Valérie Le Morvan, Virginie Charasson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 16, 2026
Induction chemotherapy followed by chemoradiotherapy in patients with locally advanced anal cancers: The PRODIGE 85-FFCD 1804-KANALRAD trialSophia Medjahdi, Stefano Kim, Claire Lemanski, et al.
Pageof 10

Showing results (11-20 of 96) with videos related to

Sort By:
Pageof 10
Pharmacogenomics|December 19, 2007
Determination of ERCC2 Lys751Gln and GSTP1 Ile105Val gene polymorphisms in colorectal cancer patients: relationships with treatment outcomeValérie Le Morvan, Denis Smith, Armelle Laurand, et al.
Pharmacogenomics|February 15, 2012
Absence of transcriptomic signature of response to chemotherapy in metastatic colorectal carcinoma patientsAudrey Laroche-Clary, Audrey Kauffmann, Denis Smith, et al.
Fundamental & Clinical Pharmacology|September 8, 2016
How are elderly patients treated after a diagnosis of metastatic colorectal cancer in real-life practice? A study in a French teaching hospitalAmandine Gouverneur, Magali Rouyer, Angela Grelaud, et al.
Journal of Chemotherapy (Florence, Italy)|October 9, 2012
Uracil-tegafur/leucovorin and mitomycin C salvage therapy in patients with advanced colorectal cancer: a phase II studyEric Francois, Denis Smith, Laetitia Dahan, et al.
Targeted Oncology|December 6, 2013
Survival outcomes of bevacizumab in first-line metastatic colorectal cancer in a real-life setting: results of the ETNA cohortAnnie Fourrier-Réglat, Denis Smith, Magali Rouyer, et al.
Colorectal Disease : the Official Journal of the Association of Coloproctology of Great Britain and Ireland|April 12, 2021
A phase III randomized trial evaluating chemotherapy followed by pelvic reirradiation versus chemotherapy alone as preoperative treatment for locally recurrent rectal cancer - GRECCAR 15 trial protocolQuentin Denost, Eric Frison, Cécile Salut, et al.
Pancreatology : Official Journal of the International Association of Pancreatology (IAP) ... [Et Al.]|August 18, 2021
Efficacy of treatments for VIPoma: A GTE multicentric seriesMathias Brugel, Thomas Walter, Bernard Goichot, et al.
Clinics and Research in Hepatology and Gastroenterology|November 22, 2017
Patient-reported tolerance in treatments approved in neuroendocrine tumors: A national survey from the French Group of Endocrine TumorsArnaud Plante, Eric Baudin, Christine Do Cao, et al.
Cancer Chemotherapy and Pharmacology|May 8, 2007
Functional study of the 830C>G polymorphism of the human carboxylesterase 2 geneRicardo Bellott, Valérie Le Morvan, Virginie Charasson, et al.
Digestive and Liver Disease : Official Journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver|January 16, 2026
Induction chemotherapy followed by chemoradiotherapy in patients with locally advanced anal cancers: The PRODIGE 85-FFCD 1804-KANALRAD trialSophia Medjahdi, Stefano Kim, Claire Lemanski, et al.
Pageof 10